These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36494358)

  • 1. Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes.
    Chen Y; Wang F; Yin L; Jiang H; Lu X; Bi Y; Zhang W; Shi Y; Burioni R; Tong Z; Song H; Qi J; Gao GF
    Nat Commun; 2022 Dec; 13(1):7603. PubMed ID: 36494358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.
    Clementi N; De Marco D; Mancini N; Solforosi L; Moreno GJ; Gubareva LV; Mishin V; Di Pietro A; Vicenzi E; Siccardi AG; Clementi M; Burioni R
    PLoS One; 2011; 6(12):e28001. PubMed ID: 22162996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem.
    Teo QW; Wang Y; Lv H; Tan TJC; Lei R; Mao KJ; Wu NC
    Cell Rep; 2023 Nov; 42(11):113410. PubMed ID: 37976161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique binding pattern for a lineage of human antibodies with broad reactivity against influenza A virus.
    Sun X; Liu C; Lu X; Ling Z; Yi C; Zhang Z; Li Z; Jin M; Wang W; Tang S; Wang F; Wang F; Wangmo S; Chen S; Li L; Ma L; Zhang Y; Yang Z; Dong X; Qian Z; Ding J; Wang D; Cong Y; Sun B
    Nat Commun; 2022 May; 13(1):2378. PubMed ID: 35501328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique structural solution from a V
    Harshbarger WD; Deming D; Lockbaum GJ; Attatippaholkun N; Kamkaew M; Hou S; Somasundaran M; Wang JP; Finberg RW; Zhu QK; Schiffer CA; Marasco WA
    Nat Commun; 2021 Jan; 12(1):559. PubMed ID: 33495478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
    J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.
    Zhu X; Han J; Sun W; Puente-Massaguer E; Yu W; Palese P; Krammer F; Ward AB; Wilson IA
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2200821119. PubMed ID: 35594401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
    Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F
    J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
    Widge AT; Hofstetter AR; Houser KV; Awan SF; Chen GL; Burgos Florez MC; Berkowitz NM; Mendoza F; Hendel CS; Holman LA; Gordon IJ; Apte P; Liang CJ; Gaudinski MR; Coates EE; Strom L; Wycuff D; Vazquez S; Stein JA; Gall JG; Adams WC; Carlton K; Gillespie RA; Creanga A; Crank MC; Andrews SF; Castro M; Serebryannyy LA; Narpala SR; Hatcher C; Lin BC; O'Connell S; Freyn AW; Rosado VC; Nachbagauer R; Palese P; Kanekiyo M; McDermott AB; Koup RA; Dropulic LK; Graham BS; Mascola JR; Ledgerwood JE;
    Sci Transl Med; 2023 Apr; 15(692):eade4790. PubMed ID: 37075129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.
    Margine I; Krammer F; Hai R; Heaton NS; Tan GS; Andrews SA; Runstadler JA; Wilson PC; Albrecht RA; García-Sastre A; Palese P
    J Virol; 2013 Oct; 87(19):10435-46. PubMed ID: 23903831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies.
    Lee CY; Raghunathan V; Caceres CJ; Geiger G; Seibert B; Cargnin Faccin F; Gay LC; Ferreri LM; Kaul D; Wrammert J; Tan GS; Perez DR; Lowen AC
    Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2208718120. PubMed ID: 37068231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Hemagglutinin Structures and Antibody Recognition.
    Wu NC; Wilson IA
    Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31871236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice.
    Retamal M; Abed Y; Rhéaume C; Cappelletti F; Clementi N; Mancini N; Clementi M; Burioni R; Boivin G
    Antimicrob Agents Chemother; 2015 May; 59(5):2647-53. PubMed ID: 25691648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus.
    Li S; Qiao Y; Xu Y; Li P; Nie J; Zhao Q; Chai W; Shi Y; Kong W; Shan Y
    Immunol Invest; 2022 Feb; 51(2):411-424. PubMed ID: 33078652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.